Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.

Frontiers in bioscience (Landmark edition) - 19 Jul 2024

Duy Le Vu, Huong Pham Thi, Nam Nguyen Trung, Trang Do Thi, Chau Nghiem Thi Minh, Thao Tran Thi Phuong, Hoang Nguyen Huy, Tao Nguyen Thien, Mao Can Van, Xuan Nguyen Thi

Abstract excerpt

BACKGROUND: Prostate cancer (PCa) is one of the most common malignant tumors of the male urinary system, and its incidence and mortality rates have been increasing worldwide. Benign prostatic hyperplasia (BPH) represents stromal and epithelial cell proliferation in the prostate in elderly males. Abnormal activation of inflammation-related signalling molecules, such as toll-like receptor 4 (TLR4) and Janus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Deubiquitinating Enzyme CYLD

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Janus Kinase 2

Share to Prostate-Specific Antigen

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Toll-Like Receptor 4

Source

Identifiers

PMID: 39082359
DOI: 10.31083/j.fbl2907256

Genes

CYLD
TLR4
JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.PMID 39082359Read ↗

Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancerSemantic proximity Read ↗

Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.Semantic proximity Read ↗

Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study.Semantic proximity Read ↗

CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.Semantic proximity Read ↗

A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study.Semantic proximity Read ↗

Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis‐Related Signature in Localized Prostate CancerSemantic proximity Read ↗

SLC25A37 is casually associated with the increased incidence of benign prostatic hyperplasiaSemantic proximity Read ↗

Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.Semantic proximity Read ↗

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Semantic proximity Read ↗

Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.